ArticlePloS one2022

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort.

Nadjoua Maouche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.